Al B Benson

Al B Benson

UNVERIFIED PROFILE

Are you Al B Benson?   Register this Author

Register author
Al B Benson

Al B Benson

Publications by authors named "Al B Benson"

Are you Al B Benson?   Register this Author

100Publications

3305Reads

44Profile Views

Oncology clinical trials and insurance coverage: An update in a tenuous insurance landscape.

Cancer 2019 Oct 28;125(20):3488-3493. Epub 2019 Jun 28.

Department of Radiology, University of Michigan School of Medicine, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32360DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763351PMC
October 2019

Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies.

J Surg Oncol 2019 Jul 16;120(1):85-92. Epub 2019 Jan 16.

Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.25374DOI Listing
July 2019

Comparison of Cancer Burden and Nonprofit Organization Funding Reveals Disparities in Funding Across Cancer Types.

J Natl Compr Canc Netw 2019 Jul;17(7):849-854

aDepartment of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2018.7280DOI Listing
July 2019

Failure to administer recommended chemotherapy: acceptable variation or cancer care quality blind spot?

BMJ Qual Saf 2019 Jul 31. Epub 2019 Jul 31.

Surgical Outcomes and Quality Improvement Center, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjqs-2019-009742DOI Listing
July 2019

Pembrolizumab for the treatment of gastric cancer.

Expert Rev Anticancer Ther 2018 12 3;18(12):1177-1187. Epub 2018 Oct 3.

a Division of Hematology/Oncology , Northwestern University Feinberg School of Medicine , Chicago , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1526084DOI Listing
December 2018

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.

Value Health 2018 09 3;21(9):1062-1068. Epub 2018 Aug 3.

Department of Clinical Pharmacy, UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10983015183226
Publisher Site
http://dx.doi.org/10.1016/j.jval.2018.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374027PMC
September 2018

Real-World Treatment Patterns for Lung Neuroendocrine Tumors: A Claims Database Analysis.

Oncology 2018 6;94(5):281-288. Epub 2018 Mar 6.

Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000486282DOI Listing
May 2018

Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).

J Clin Oncol 2018 04 28;36(11):1112-1120. Epub 2018 Feb 28.

Temidayo Fadelu, Sui Zhang, Robert J. Mayer, Shuji Ogino, Kimmie Ng, Jeffrey Meyerhardt, and Charles S. Fuchs, Dana-Farber/Partners CancerCare; Shuji Ogino, Kana Wu, Walter Willett, and Edward Giovannucci, Harvard TH Chan School of Public Health; Shuji Ogino, Edward Giovannucci, and Ying Bao, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA; Donna Niedzwiecki and Xing Ye, Alliance Statistics and Data Center, Duke University, Durham; Michael Messino, Southeast Clinical Oncology Research Consortium, Mission Hospitals, Asheville, NC; Leonard B. Saltz, Memorial Sloan Kettering Cancer Center, New York, NY; Rex B. Mowat, Toledo Community Hospital Oncology Program, Toledo, OH; Renaud Whittom, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada; Alexander Hantel, Loyola University Stritch School of Medicine, Naperville; Al B. Benson, Robert H Lurie Comprehensive Cancer Center, Northwestern University; Hedy L. Kindler, University of Chicago Comprehensive Cancer, Chicago, IL; Daniel M. Atienza, Virginia Oncology Associates, Norfolk, VA; Alan Venook, University of California at San Francisco Comprehensive Cancer Center, San Francisco, CA; and Charles S. Fuchs, Yale Cancer Center, Yale School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5413DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891130PMC
April 2018

Personalizing Adjuvant Therapy for Stage II/III Colorectal Cancer.

Am Soc Clin Oncol Educ Book 2017 ;37:232-245

From the Dana-Farber Cancer Institute, Boston, MA; Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain; Sage Bionetworks, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175660DOI Listing
December 2017

Long-Term Hepatotoxicity of Yttrium-90 Radioembolization as Treatment of Metastatic Neuroendocrine Tumor to the Liver.

J Vasc Interv Radiol 2017 Nov 30;28(11):1520-1526. Epub 2017 Jun 30.

Department of Radiology, Northwestern University Feinberg School of Medicine, 676 N. St. Clair St., Chicago, IL 60611-2927. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2017.05.011DOI Listing
November 2017

Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors.

Am Health Drug Benefits 2017 Nov;10(8):408-415

Professor of Medicine, and Associate Director for Cooperative Groups, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726060PMC
November 2017

Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LAR.

J Med Econ 2017 Sep 19;20(9):945-951. Epub 2017 Jun 19.

c Robert H. Lurie Comprehensive Cancer Center of Northwestern University , Chicago , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13696998.2017.1337019DOI Listing
September 2017

Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis.

World J Gastroenterol 2017 09;23(33):6128-6136

Partnership for Health Analytic Research, LLC, Beverly Hills, CA 90212, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v23.i33.6128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597504PMC
September 2017

Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).

J Clin Oncol 2017 Mar 9;35(7):718-726. Epub 2017 Jan 9.

Madhur K. Garg, Joseph A. Sparano, and Shalom Kalnicki, Montefiore Medical Center, Albert Einstein College of Medicine, Montefiore-Einstein Center for Cancer Care, Bronx, NY; Fengmin Zhao, Dana Farber Cancer Institute, Boston, MA; Joel Palefsky, University of California, San Francisco, CA; Richard Whittington, Philadelphia VA Medical Center; Edith P. Mitchell, Thomas Jefferson University, Philadelphia, PA; Mary F. Mulcahy and Al B. Benson III, Northwestern University, Chicago, IL; Karin I. Armstrong, United Hospital, Woodbury, MN; Nassim H. Nabbout, Cancer Center of Kansas, Wichita, KS; Bassel F. El-Rayes, Emory University, Atlanta, GA; Adedayo A. Onitilo, Marshfield Clinic, Marshfield, WI; Daniel J. Moriarty, Overlook Medical Center, Summit, NJ; and Thomas J. Fitzgerald, Imaging and Radiation Oncology Core, Quality Assurance Review Center, Providence, RI.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.69.1667
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.69.1667DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455423PMC
March 2017

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology.

J Clin Oncol 2017 Feb 14;35(4):446-464. Epub 2016 Nov 14.

Angela N. Bartley, St Joseph Mercy Hospital, Ann Arbor, MI; Mary Kay Washington, Vanderbilt University Medical Center, Nashville, TN; Carol Colasacco and Christina B. Ventura, College of American Pathologists, Northfield; Al B. Benson III, Northwestern University, Chicago, IL; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Alfredo Carrato, Ramón y Cajal University Hospital, Madrid, Spain; Margaret L. Gulley, University of North Carolina, Chapel Hill, NC; Dhanpat Jain, Yale University School of Medicine, New Haven, CT; Sanjay Kakar, University of California, San Francisco, CA; Helen J. Mackay, Princess Margaret Cancer Centre; Catherine Streutker, St Michael's Hospital, University of Toronto, Toronto, Canada; Laura Tang, Memorial Sloan Kettering Cancer Center, New York, NY; Megan Troxell, Stanford University Medical Center, Stanford, CA; and Jaffer A. Ajani, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.4836DOI Listing
February 2017

Targeting Angiogenesis in Colorectal Cancer: Tyrosine Kinase Inhibitors.

Cancer J 2016 May-Jun;22(3):182-9

From the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000192DOI Listing
January 2017

Epidemiology of Anal Canal Cancer.

Surg Oncol Clin N Am 2017 01;26(1):9-15

Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, 676 N Saint Clair, Suite 850, Chicago, IL 60611, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2016.07.001DOI Listing
January 2017

Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.

Gastroenterology 2016 12 27;151(6):1155-1163.e2. Epub 2016 Aug 27.

Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois; Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2016.08.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124387PMC
December 2016

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.

Arch Pathol Lab Med 2016 Dec 14;140(12):1345-1363. Epub 2016 Nov 14.

From the Department of Pathology, St. Joseph Mercy Hospital, Ann Arbor, Michigan (Dr Bartley); the Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Washington); Surveys (Ms Ventura) and Governance (Ms Colasacco), College of American Pathologists, Northfield, Illinois; Quality and Guidelines Department, American Society of Clinical Oncology, Alexandria, Virginia (Dr Ismaila); the Division of Hematology/Oncology, Northwestern University, Chicago, Illinois (Dr Benson); Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain (Dr Carrato); the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill (Dr Gulley); the Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (Dr Jain); the Department of Pathology and Laboratory Medicine, UCSF, San Francisco, California (Dr Kakar); the Division of Medical Oncology and Hematology, University of Toronto/Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada (Dr Mackay); the Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada (Dr Streutker); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Tang); the Department of Pathology, Stanford University Medical Center, Stanford, California (Dr Troxell); and the Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston (Dr Ajani).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0331-CPDOI Listing
December 2016

Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy.

J Natl Compr Canc Netw 2016 12;14(12):1528-1534

From Division of Surgical Oncology, The Ohio State University Wexner Medical Center/Arthur G. James Cancer Hospital, Columbus, Ohio; Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, Ohio; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; City of Hope Comprehensive Cancer Center, Duarte, California; University of Texas MD Anderson Cancer Center, Houston, Texas; Kalispell Regional Healthcare Specialists, Kalispell Regional Healthcare, Kalispell, Montana; Memorial Sloan Kettering Cancer Center, New York, New York; Dana-Farber Cancer Institute, Boston, Massachusetts; and Depaartment of Medicine, Division of Hematology/Oncology, Mayo Clinic Cancer Center, Phoenix, Arizona.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292039PMC
http://dx.doi.org/10.6004/jnccn.2016.0164DOI Listing
December 2016

Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care Delivery.

J Oncol Pract 2016 11 31;12(11):1101-1113. Epub 2016 Oct 31.

Center for Business Models in Healthcare; Northwestern University, Chicago, IL; University of Michigan Health System; University of Michigan Medical School, Ann Arbor, MI; ECOG/ACRIN Cancer Research Group, Philadelphia, PA; National Breast Cancer Coalition, Washington, DC; Genentech, South San Francisco, CA; Albert Einstein Cancer Center; Albert Einstein College of Medicine, Bronx; The Leukemia & Lymphoma Society, Rye Brook, NY; Brown University School of Public Health, Providence, RI; Wake Forest University School of Medicine; and Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.013573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455414PMC
November 2016

Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach.

Pancreas 2016 11;45(10):1485-1493

From the *Yale Center for Pancreatic Disease, Yale School of Medicine, New Haven, CT; †Statistics and Data Management Center, NRG Oncology, Philadelphia, PA; ‡Department of Medicine, John A Burns School of Medicine, University of Hawaii, Honolulu, HI; §Department of Radiation Oncology, University of Maryland, Baltimore, MD; ∥Oncology Program, Toledo Clinic, Toledo, OH; ¶Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; #Saint Vincent Comprehensive Cancer Center, New York; and **The Oncology Consortia of Criterium Inc, Saratoga Springs, NY; ††California Cancer Institute, Temple City, CA; ‡‡Graduate Institute of Medical Sciences, College of Medicine, and §§Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan; ∥∥Department of Pathology, Cross Cancer Center, University of Alberta, Edmonton, Alberta, Canada; ¶¶Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, FL; ##Karmanos Cancer Institute; and ***Department of Oncology and Cancer Biology Graduate Program, Wayne State University, Detroit, MI; †††Department of Radiation Oncology, Montifiore Medical Center, Bronx, NY; and ‡‡‡Department of Radiation Oncology, The Canberra Hospital, Australian National University, Canberra, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119656PMC
November 2016

Should we consider adjuvant therapy for rectal cancer after neoadjuvant chemoradiotherapy?

Authors:
Al B Benson

Clin Adv Hematol Oncol 2016 Oct;14(10):778-781

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
October 2016

Is There Efficacy Beyond Cytotoxic Chemotherapy for Pancreatic Cancer?

J Oncol Pract 2016 09;12(9):806-7

Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.015883DOI Listing
September 2016

Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study.

Am J Clin Oncol 2016 08;39(4):340-5

*Department of Medical Oncology, Fox Chase Cancer Center ∥Department of Internal Medicine, Thomas Jefferson University School of Medicine, Philadelphia, PA †Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA ‡Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN §East Carolina University School of Medicine, Greenville, NC ¶Lurie Cancer Center, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177955PMC
August 2016

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2016 08 31;34(22):2654-68. Epub 2016 May 31.

Edward P. Balaban, Cancer Care Partnership, State College; Edward P. Balaban and Nelson S. Yee, Penn State Hershey Cancer Institute, Hershey, PA; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Alok A. Khorana, Cleveland Clinic; Jennifer R. Eads, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH; Manish A. Shah, The Weill Cornell Medical Center; Peter Allen, Memorial Sloan Kettering Cancer Center, New York, NY; Somnath Mukherjee, University of Oxford, Oxford, United Kingdom; Christopher H. Crane and Milind M. Javle, The University of Texas MD Anderson Cancer Center, Houston, TX; Andrew H. Ko, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; Anitra Engebretson, Patient Representative, Portland, OR; Joseph M. Herman, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; John H. Strickler, Duke University Medical Center, Durham, NC; Al B. Benson III, Lurie Comprehensive Cancer Center of Northwestern, Chicago, IL; and Susan Urba, University of Michigan Cancer Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.5561DOI Listing
August 2016

90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.

J Nucl Med 2016 May 3;57(5):665-71. Epub 2015 Dec 3.

Section of Interventional Radiology, Department of Radiology, Robert H. Lurie Comprehensive Cancer Center, Northwestern Memorial Hospital, Chicago, Illinois Division of Hematology and Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.166082DOI Listing
May 2016

Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.

Clin Colorectal Cancer 2016 Mar 26;15(1):37-46. Epub 2015 Jul 26.

Center for Pain Studies, Rehabilitation Institute of Chicago and Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2015.07.001DOI Listing
March 2016

Adjusted Hospital Sentinel Lymph Node Positivity Rates in Melanoma: A Novel Potential Measure of Quality.

Ann Surg 2016 Feb;263(2):392-8

*Northwestern Institute for Comparative Effectiveness Research (NICER) in Oncology, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL †Surgical Oncology and Quality Improvement Center, Department of Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL ‡Department of Surgery, Massachusetts General Hospital, Boston, MA §Division of Research and Optimal Patient Care, American College of Surgeons, Chicago, IL ¶Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, IL ||Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL **Cancer Programs, American College of Surgeons, Chicago, IL ††Department of Surgery, NorthShore University HealthSystem, Evanston, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001052DOI Listing
February 2016

Young Age and Aggressive Treatment in Colon Cancer.

JAMA 2015 Aug;314(6):613-4

Department of Surgery, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.20
Publisher Site
http://dx.doi.org/10.1001/jama.2015.9379DOI Listing
August 2015

NCCN Evolving Through the Decades: A Continuum of Commitment and Mission.

Authors:
Al B Benson

J Natl Compr Canc Netw 2015 Jul;13(7):833-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0100DOI Listing
July 2015

Rectal Cancer, Version 2.2015.

J Natl Compr Canc Netw 2015 Jun;13(6):719-28; quiz 728

Robert H. Lurie Comprehensive Cancer Center of Northwestern University; UCSF Helen Diller Family Comprehensive Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Vanderbilt-Ingram Cancer Center; City of Hope Comprehensive Cancer Center; Fox Chase Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Fred & Pamela Buffett Cancer Center; Mayo Clinic Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; University of Alabama at Birmingham Comprehensive Cancer Center; Stanford Cancer Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Colorado Cancer Center; UC San Diego Moores Cancer Center; Roswell Park Cancer Institute; The University of Texas MD Anderson Cancer Center; Massachusetts General Hospital Cancer Center; Memorial Sloan Kettering Cancer Center; Huntsman Cancer Institute at the University of Utah; Moffitt Cancer Center; University of Michigan Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Duke Cancer Institute; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0087DOI Listing
June 2015

Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study.

Ann Surg 2015 Apr;261(4):702-7

*Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA †Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Harvard School of Public Health, Boston, MA ‡Department of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA §Division of Hematology/Oncology, Department of Medicine, Northwestern University, Chicago, IL ¶Division of Thoracic and Foregut Surgery, Department of Surgery, University of Minnesota, Minneapolis ‖Division of Gastrointestinal Surgery, Department of Surgery, University of California Irvine Medical Center, Orange, CA **Department of Cardiothoracic Surgery, Boston Medical Center, Boston, MA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074683PMC
http://dx.doi.org/10.1097/SLA.0000000000000993DOI Listing
April 2015

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

J Natl Cancer Inst 2015 Jan 27;107(1):345. Epub 2014 Nov 27.

: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (KN, JAM, KS, JAC, RJM, SO, CSF); Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC); Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (ATC, ELG, CSF); Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC (DN); Memorial Sloan-Kettering Cancer Center, New York, NY (LBS); Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL (ABB); Toledo Community Hospital Oncology Program, Toledo, OH (PLS); Hopital du Sacre-Coeur de Montreal, Universite de Montreal, Quebec, Canada (RW); Edward Cancer Center, Naperville, IL (AH); Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH (RMG); Division of Medical Oncology, University of California at San Francisco, San Francisco, CA (APV); Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (SO); Department of Epidemiology (SO, ELG) and Department of Nutrition (ELG), Harvard School of Public Health, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271076PMC
January 2015

Colon cancer: the new chronic disease.

Authors:
Al B Benson

J Natl Compr Canc Netw 2014 Nov;12(11):1497-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0148DOI Listing
November 2014

Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.

Eur J Nucl Med Mol Imaging 2014 Oct 7;41(10):1861-9. Epub 2014 Jun 7.

Department of Radiology, Section of Interventional Radiology, Northwestern Memorial Hospital, Robert H. Lurie Comprehensive Cancer Center, 676 N. St. Clair, Suite 800, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-014-2799-2DOI Listing
October 2014

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

J Natl Cancer Inst 2014 Oct 12;106(10). Epub 2014 Sep 12.

Northwestern University Feinberg School of Medicine, Chicago, IL (JCS, JRT, CBW, KPS, AWR, JDP, ABB, WJG); Center for Business Models in Healthcare, Chicago, IL (JRT, CBW); UCSF Center for Translational and Policy Research on Personalized Medicine, Department of Clinical Pharmacy, University of California, San Francisco, CA (JRT); Department of Pathology, Dartmouth Hitchcock Medical Center and the Audrey and Theodor Geisel School of Medicine, Dartmouth College, Lebanon, NH (GJT); Mayo Clinic Cancer Center, Mayo Clinic, Jacksonville, FL (EAP).* Current affiliation: Spectrum Health Medical Group, Grand Rapids, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176043PMC
October 2014

Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review study.

Oncologist 2014 Sep 5;19(9):930-6. Epub 2014 Aug 5.

Department of Gastrointestinal Oncology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA; Analysis Group, Inc., Boston, Massachusetts, USA; Department of Internal Medicine, University of South Florida, Tampa, Florida, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153451PMC
September 2014

Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.

J Natl Compr Canc Netw 2014 Aug;12(8):1083-93

From UCSF Helen Diller Family Comprehensive Cancer Center; Moffitt Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; City of Hope Comprehensive Cancer Center; Fox Chase Cancer Center; Duke Cancer Institute; Pancreatic Cancer Action Network (PanCAN); University of Michigan Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Stanford Cancer Institute; UC San Diego Moores Cancer Center; Roswell Park Cancer Institute; Vanderbilt-Ingram Cancer Center; Huntsman Cancer Institute at the University of Utah; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Massachusetts General Hospital Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; University of Colorado Cancer Center; The University of Texas MD Anderson Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0106DOI Listing
August 2014

Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer.

J Natl Compr Canc Netw 2014 Aug;12(8):1123-30

From Fox Chase Cancer Center, Philadelphia, Pennsylvania; City of Hope Comprehensive Cancer Center, Duarte, California; Dana-Farber Cancer Institute, Boston, Massachusetts; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, Ohio; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois; The University of Texas MD Anderson Cancer Center, Houston, Texas; Memorial Sloan Kettering Cancer Center, New York, New York; and Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0109DOI Listing
August 2014

Adjuvant chemotherapy for stage II colon cancer: everyone still needs a tailor.

Ann Surg Oncol 2014 Jun 14;21(6):1765-7. Epub 2014 Mar 14.

Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-3635-4DOI Listing
June 2014

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.

J Clin Oncol 2014 May 24;32(13):1365-83. Epub 2014 Mar 24.

Gary H. Lyman, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; Lisa A. Newman and James Hayman, University of Michigan, Ann Arbor, MI; Roderick R. Turner, John Wayne Cancer Institute, Santa Monica; Linda D. Bosserman, Wilshire Oncology Medical Group, Rancho Cucamonga; Armando E. Giuliano, Cedars-Sinai Medical Center, Los Angeles, CA; Donald L. Weaver, University of Vermont College of Medicine and Vermont Cancer Center, Burlington, VT; Al B. Benson III, Northwestern University, Chicago, IL; Harold J. Burstein, Dana-Farber Cancer Institute, Boston, MA; Hiram Cody III, Memorial Sloan Kettering Cancer Center, New York, NY; Cheryl L. Perkins, Patient Representative, Dallas; and Donald A. Podoloff, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.1177DOI Listing
May 2014

Reply to C.C. Earle.

J Clin Oncol 2014 May 14;32(14):1518-9. Epub 2014 Apr 14.

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.4030DOI Listing
May 2014

International adaptations of NCCN Clinical Practice Guidelines in Oncology.

J Natl Compr Canc Netw 2014 May;12(5):643-8

From aNational Comprehensive Cancer Network, Fort Washington, Pennsylvania; bFox Chase Cancer Center, Philadelphia, Pennsylvania; cUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; dRobert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois; and eUniversity of Washington/Seattle Cancer Care Alliance, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0068DOI Listing
May 2014

Important and relevant symptoms including pain concerns in hepatocellular carcinoma (HCC): a patient interview study.

Support Care Cancer 2014 Apr 21;22(4):919-26. Epub 2013 Nov 21.

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 625 N. Michigan Avenue, Suite 2700, Chicago, IL, 60611, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-013-2039-5DOI Listing
April 2014

Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization.

Int J Radiat Oncol Biol Phys 2014 Apr;88(5):1025-31

Department of Radiology, Section of Interventional Radiology, Northwestern Memorial Hospital, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois; Division of Hematology and Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2013.12.040DOI Listing
April 2014

Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement.

J Clin Oncol 2013 Dec 12;31(35):4465-70. Epub 2013 Nov 12.

Jeffrey A. Meyerhardt and Deborah H. Schrag, Dana-Farber Cancer Institute, Boston, MA; Pamela B. Mangu, American Society of Clinical Oncology; Kim Ryan, Fight Colorectal Cancer, Alexandria, VA; Patrick J. Flynn, Minnesota Oncology, Minneapolis; Charles L. Loprinzi, Mayo Clinic, Rochester, MN; Larissa Korde, University of Washington, Seattle, WA; Bruce D. Minsky, MD Anderson Cancer Center, Houston, TX; Nicholas J. Petrelli, Helen Graham Cancer Center, Newark, DE; Sandra L. Wong, University of Michigan Medical School, Ann Arbor, MI; and Al B. Benson III, Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.50.7442
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.50.7442DOI Listing
December 2013

S-1: another oral agent for patients with colorectal cancer.

Authors:
Al B Benson

Lancet Oncol 2013 Dec 11;14(13):1244-5. Epub 2013 Nov 11.

Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70533-3DOI Listing
December 2013

Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.

J Natl Cancer Inst 2013 Dec 14;105(23):1789-98. Epub 2013 Nov 14.

Affiliations of authors: Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (SO, XL, YI, MY, NJM, KN, RJM, JAM, CSF); Department of Pathology (SO), Channing Division of Network Medicine, Department of Medicine (DS, CSF), and Department of Surgery (MMB), Brigham and Women's Hospital and Harvard Medical School, Boston, MA (SO); Department of Epidemiology (SO, DS) and Department of Biostatistics (DS) , Harvard School of Public Health, Boston, MA; Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC (DN); Memorial Sloan-Kettering Cancer Center, New York, NY (LBS); Hôpital du Sacré-Coeur de Montréal, Montreal, Canada (RW); Loyola University Stritch School of Medicine, Maywood, IL (AH); current: Edward Cancer Center, Naperville, IL (AH); Northwestern University, Chicago, IL (ABB); Toledo Community Hospital Oncology Program, Toledo, OH (RBM); Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH (RMG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848984PMC
December 2013

Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization.

Clin Gastroenterol Hepatol 2013 Oct 2;11(10):1358-1365.e1. Epub 2013 May 2.

Department of Radiology, Division of Interventional Oncology, Northwestern University, Chicago, Illinois; Department of Medicine, Division of Hematology/Oncology, Northwestern University, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2013.04.028DOI Listing
October 2013

Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study.

Eur J Cancer 2013 Oct 15;49(15):3122-30. Epub 2013 Jun 15.

Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.05.012DOI Listing
October 2013

Status of targeted therapies in the adjuvant treatment of colon cancer.

J Gastrointest Oncol 2013 Sep;4(3):245-52

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2078-6891.2013.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712301PMC
September 2013

A decade of progress for patients with metastatic colorectal cancer: a new decade in which obstacles loom.

Authors:
Al B Benson

J Natl Compr Canc Netw 2013 Sep;11 Suppl 4:S1-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2013.0216DOI Listing
September 2013

Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.

J Vasc Interv Radiol 2013 Aug 19;24(8):1227-34. Epub 2013 Apr 19.

Department of Radiology/Section of Interventional Radiology, Northwestern Memorial Hospital, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2013.02.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800023PMC
August 2013

Preoperative chemotherapy for locally advanced resectable colon cancer - a new treatment paradigm in colon cancer?

Ann Transl Med 2013 Jul;1(2):11

Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL. 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2305-5839.2013.01.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200631PMC
July 2013

Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy.

Curr Oncol Rep 2013 Apr;15(2):152-61

Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60601, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11912-013-0297-5
Publisher Site
http://dx.doi.org/10.1007/s11912-013-0297-5DOI Listing
April 2013

Data acquisition, tumor heterogeneity and precision medicine: future challenges for oncologic comparative effectiveness research.

Authors:
Al B Benson

J Comp Eff Res 2013 Jan;2(1):17-21

Northwestern University, Division of Hematology/Oncology, 676 N St Clair Street, Suite 850, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer.12.76DOI Listing
January 2013